First-pass extracted concept

sonodynamic therapy

Candidate: concept label5 source documents5 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

SDT

Extracted Explainers

What the tool is doing

SDT uses ultrasound-activated nanosensitizers to generate cytotoxic ROS. The abstract states this supports targeted ablation of inflammatory cells in RA.

Source 1DOIPubMed

SDT is named as one of the ultrasound-based therapeutic application areas discussed in the review.

Source 3DOIPubMed

Resources required

This modality requires nanosensitizers that respond to ultrasound and an ultrasound activation setup.

Source 1DOIPubMed

What problem it solves

It is presented as a targeted way to remove inflammatory cells contributing to RA pathology.

Source 1DOIPubMed

Evidence Snippets

SDT employs ultrasound-activated nanosensitizers to produce cytotoxic ROS for the targeted ablation of inflammatory cells.
Evidence 1Source 1DOIPubMedprovenance
synergistic multimodal therapies, including chemodynamic therapy, sonodynamic therapy, photothermal therapy, immunotherapy, photodynamic therapy, and gas therapy
Evidence 2Source 2DOIPubMedprovenance
We examine the biophysical mechanisms underlying US-based therapies, the design of multifunctional nanoplatforms, and their applications in enhanced imaging, high-intensity focused ultrasound (HIFU), sonodynamic therapy (SDT), and US-triggered drug delivery.
Evidence 3Source 3DOIPubMedprovenance
The review frames the field around biomimetic carriers for sonodynamic therapy in cancer.
Evidence 4Source 4DOIPubMedprovenance
We discuss the applications of ultrasound-responsive nanoparticles in brain tumor therapy, including enhanced radiotherapy, gene delivery, immunotherapy, and sonodynamic therapy (SDT).
Evidence 5Source 5DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1mechanismsupports2026Source 1DOIPubMed

Sonodynamic therapy uses ultrasound-activated nanosensitizers to produce cytotoxic ROS for targeted ablation of inflammatory cells.

Quoted textsource-backed
SDT employs ultrasound-activated nanosensitizers to produce cytotoxic ROS for the targeted ablation of inflammatory cells.
Claim 2application scopesupports2025Source 3DOIPubMed

Nanoparticle-ultrasound synergy is applied in enhanced imaging, HIFU, sonodynamic therapy, and ultrasound-triggered drug delivery for breast and gynecologic cancers.

Quoted textsource-backed
We examine the biophysical mechanisms underlying US-based therapies, the design of multifunctional nanoplatforms, and their applications in enhanced imaging, high-intensity focused ultrasound (HIFU), sonodynamic therapy (SDT), and US-triggered drug delivery.
Claim 3application scopesupports2025Source 5DOIPubMed

Ultrasound-responsive nanoparticles are applied in brain tumor therapy for enhanced radiotherapy, gene delivery, immunotherapy, and sonodynamic therapy.

Claim 4scope statementsupports2025Source 4DOIPubMed

The source frames sonodynamic biomimetic-nanomedicine as a cancer-focused field centered on biomimetic carriers for sonodynamic therapy.

Claim 5therapeutic strategysupports2025Source 2DOIPubMed

Micro/nano-motors are described as advantageous for synergistic multimodal tumor therapies including chemodynamic, sonodynamic, photothermal, immunotherapy, photodynamic, and gas therapy.

Quoted textsource-backed
we discuss the therapeutic mechanisms of MNMs within the tumor microenvironment in detail and highlight the advantages of synergistic multimodal therapies, including chemodynamic therapy, sonodynamic therapy, photothermal therapy, immunotherapy, photodynamic therapy, and gas therapy.